HRAS and cancer: Various cell types were sensitized to NSC-105808 through oncogene expression (H-RAS, K-RAS, or human papillomavirus E6 and E7), suggesting that DNA2i may have the potential to act in a broad range of cancers characterized by endogenous replication stress.